Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    March 2017
  1. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. YU L, Di Y, Xin L, Ren Y, et al
    SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFbeta1 response and breast cancer metastasis.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  3. WU MJ, Kim MR, Chen YS, Yang JY, et al
    Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCzeta pathway.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  4. LIN C, Liao W, Jian Y, Peng Y, et al
    CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  5. JHAN JR, Andrechek ER
    Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Oncogene. 2017 Jan 30. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  6. HE Y, Northey JJ, Pelletier A, Kos Z, et al
    The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    Oncogene. 2017 Jan 30. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  7. YANG N, Wang C, Wang Z, Zona S, et al
    FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. CRISTOBAL I, Zazo S, Torrejon B, Pedregal M, et al
    CIP2A confirms its prognostic value in triple-negative breast cancer.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format    


  9. ZHOU H, Liu Y, Zhu R, Ding F, et al
    FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  10. FENG J, Li L, Zhang N, Liu J, et al
    Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  11. YU L, Liang Y, Cao X, Wang X, et al
    Identification of MYST3 as a novel epigenetic activator of ERalpha frequently amplified in breast cancer.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  12. HIKEN JF, McDonald JI, Decker KF, Sanchez C, et al
    Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  13. TANG X, Ding CK, Wu J, Sjol J, et al
    Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  14. BLOMME A, Costanza B, de Tullio P, Thiry M, et al
    Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  15. YANG C, Li Z, Bhatt T, Dickler M, et al
    Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  16. HARROD A, Fulton J, Nguyen VT, Periyasamy M, et al
    Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  17. MIMOTO R, Imawari Y, Hirooka S, Takeyama H, et al
    Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  18. LONE MU, Baghel KS, Kanchan RK, Shrivastava R, et al
    Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.
    Oncogene. 2016 Oct 10. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  19. LIU H, Qiu H, Song Y, Liu Y, et al
    Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.
    Oncogene. 2016 Oct 3. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  20. LEFORT S, Thuleau A, Kieffer Y, Sirven P, et al
    CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  21. YU PF, Huang Y, Xu CL, Lin LY, et al
    Downregulation of CXCL12 in mesenchymal stromal cells by TGFbeta promotes breast cancer metastasis.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  22. KWAK T, Drews-Elger K, Ergonul A, Miller PC, et al
    Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  23. CHANG SS, Yamaguchi H, Xia W, Lim SO, et al
    Aurora A kinase activates YAP signaling in triple-negative breast cancer.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  24. KANG MH, Jeong KJ, Kim WY, Lee HJ, et al
    Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  25. TOMINAGA K, Shimamura T, Kimura N, Murayama T, et al
    Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
    Oncogene. 2016 Aug 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  26. XU Y, Qin L, Sun T, Wu H, et al
    Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  27. YU PF, Huang Y, Han YY, Lin LY, et al
    TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  28. SAHA SK, Choi HY, Kim BW, Dayem AA, et al
    KRT19 directly interacts with beta-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  29. XU LZ, Li SS, Zhou W, Kang ZJ, et al
    p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  30. FERRER CM, Lu TY, Bacigalupa ZA, Katsetos CD, et al
    O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  31. WERDEN SJ, Sphyris N, Sarkar TR, Paranjape AN, et al
    Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  32. DA MOTTA LL, Ledaki I, Purshouse K, Haider S, et al
    The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  33. RAMADOSS S, Guo G, Wang CY
    Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  34. CAO C, Vasilatos SN, Bhargava R, Fine JL, et al
    Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Oncogene. 2016 May 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  35. FARMAKI E, Chatzistamou I, Kaza V, Kiaris H, et al
    A CCL8 gradient drives breast cancer cell dissemination.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  36. HEIN AL, Post CM, Sheinin YM, Lakshmanan I, et al
    RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  37. MENDOZA-VILLANUEVA D, Balamurugan K, Ali HR, Kim SR, et al
    The C/EBPdelta protein is stabilized by estrogen receptor alpha activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
    Oncogene. 2016 May 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  38. TURPIN J, Ling C, Crosby EJ, Hartman ZC, et al
    The ErbB2DeltaEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  39. TEO WW, Merino VF, Cho S, Korangath P, et al
    HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  40. MONTENEGRO MF, Sanchez-Del-Campo L, Gonzalez-Guerrero R, Martinez-Barba E, et al
    Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis.
    Oncogene. 2016 May 2. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  41. CROSS AM, Wilson AL, Guerrero MS, Thomas KS, et al
    Breast cancer antiestrogen resistance 3-p130 interactions promote adhesion disassembly and invasion in breast cancer cells.
    Oncogene. 2016 Apr 25. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  42. GUPTA A, Hossain MM, Miller N, Kerin M, et al
    NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2alpha-ATF4 signalling in breast cancer.
    Oncogene. 2016 Apr 25. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  43. BHATT S, Stender JD, Joshi S, Wu G, et al
    OCT-4: a novel estrogen receptor-alpha collaborator that promotes tamoxifen resistance in breast cancer cells.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  44. ENGLUND E, Bartoschek M, Reitsma B, Jacobsson L, et al
    Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  45. MAO X, Gauche C, Coughtrie MW, Bui C, et al
    The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  46. ZHOU JZ, Riquelme MA, Gu S, Kar R, et al
    Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  47. MORRISON MM, Williams MM, Vaught DB, Hicks D, et al
    Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.
    Oncogene. 2016;35:1206.
    PubMed     Text format    


    February 2016
  48. MUKHERJEE S, Manna A, Bhattacharjee P, Mazumdar M, et al
    Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4 migrating cancer stem cells.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  49. JOHNSON J, Thijssen B, McDermott U, Garnett M, et al
    Targeting the RB-E2F pathway in breast cancer.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  50. ZHANG ZM, Wu JF, Luo QC, Liu QF, et al
    Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/beta-catenin pathway.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  51. FABRIS L, Berton S, Citron F, D'Andrea S, et al
    Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  52. CHAN JY, LaPara K, Yee D
    Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  53. WRIGHT HJ, Arulmoli J, Motazedi M, Nelson LJ, et al
    CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  54. PAAUWE M, Heijkants RC, Oudt CH, van Pelt GW, et al
    Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  55. TANDON M, Chen Z, Othman AH, Pratap J, et al
    Role of Runx2 in IGF-1Rbeta/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  56. TENG Y, Pi W, Wang Y, Cowell JK, et al
    WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  57. CONLEY SJ, Bosco EE, Tice DA, Hollingsworth RE, et al
    HER2 drives Mucin-like 1 to control proliferation in breast cancer cells.
    Oncogene. 2016 Jan 4. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    December 2015
  58. LI L, Fang R, Liu B, Shi H, et al
    Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.
    Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  59. OBERMEIER K, Sachsenweger J, Friedl TW, Pospiech H, et al
    Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
    Oncogene. 2015 Dec 7. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  60. PARK UH, Kang MR, Kim EJ, Kwon YS, et al
    ASXL2 promotes proliferation of breast cancer cells by linking ERalpha to histone methylation.
    Oncogene. 2015 Dec 7. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  61. BHARTI R, Dey G, Ojha PK, Rajput S, et al
    Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer.
    Oncogene. 2015 Nov 30. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  62. HONG SM, Park CW, Kim SW, Nam YJ, et al
    NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer.
    Oncogene. 2015 Nov 16. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: